Techlife-backed XPATH Groupe acquires SIPATH from Unilabs

PUBT · 1d ago
Techlife-backed XPATH Groupe acquires SIPATH from Unilabs
  • XPATH Groupe, backed by Techlife Capital, acquired SIPATH from Unilabs, adding an anatomical and cytological pathology lab in Clermont-Ferrand.
  • The deal brings 12 pathologists and 74 employees, adding EUR 18 million of revenue.
  • XPATH said the transaction opens a sixth regional hub, strengthening its coverage in central France.
  • The group said it now has more than 50 pathologists and more than EUR 50 million in revenue.
  • The acquisition was described as XPATH’s 11th since inception.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Techlife Capital SAS published the original content used to generate this news brief on September 22, 2026, and is solely responsible for the information contained therein.